Skip to main content
logo
Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
22.68
+1.12 (5.19%)
At close: Jul 30, 2026, 4:00 PM EDT
22.90
+0.22 (0.97%)
After-hours: Jul 30, 2026, 7:34 PM EDT

Monte Rosa Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-130.01-38.63-72.7-135.35-108.5-73.96
Depreciation & Amortization
8.348.368.126.223.752.13
Stock-Based Compensation
19.5218.8718.1316.6711.665.2
Other Adjustments
-2.1-2.2-2.95-3.812.760.98
Change in Receivables
-3.2-11.430.331.9-0.19-0.7
Changes in Accounts Payable
1.54-13.716.255.76-0.746.59
Changes in Accrued Expenses
6.757.854.183.561.031.11
Changes in Unearned Revenue
87.267.5283.3850--
Changes in Other Operating Activities
-2.760.57-2.7511.25-2.23-0.71
Operating Cash Flow
-14.68-22.842-43.8-92.47-59.36
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-4.98-4.7-3.99-19.04-12.91-9.73
Sale of Property, Plant & Equipment
---0.060.110.08
Purchases of Investments
-570.66-376.68-230.36-103.15-384.42-
Proceeds from Sale of Investments
313.04279.54189.9210.93178-
Investing Cash Flow
-262.6-101.83-44.4588.8-219.22-9.65

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
334.5330.7199.5327.6120.83237.9
Net Common Stock Issued (Repurchased)
334.5330.7199.5327.6120.83237.9
Issuance of Preferred Stock
-----143
Net Preferred Stock Issued (Repurchased)
-----143
Other Financing Activities
-0.49-0.36-0.64-0.12-0.36-3.34
Financing Cash Flow
358.6730.3598.8927.4920.47377.56

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
159.85-94.2896.4472.49-291.22308.55

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-19.66-27.538.01-62.84-105.38-69.1
Free Cash Flow Growth
------
FCF Margin
-45.76%-22.23%50.26%---
Free Cash Flow Per Share
-0.22-0.330.51-1.22-2.23-2.76
Levered Free Cash Flow
-33.87-32.7322.5-77.6-119.61-74.57
Unlevered Free Cash Flow
-50.03-46.8211.11-85.92-123.5-73.49
SEC Filings: 10-K · 10-Q